HHS, Regeneron collaborate on coronavirus treatment

HHS said Feb. 4 it is working with Regeneron Pharmaceuticals to develop a treatment for the coronavirus. 

Advertisement

The agency said it will work to develop multiple monoclonal antibodies, which help block a virus from infecting human cells. 

Regeneron previously worked on a similar treatment for Ebola and MERS. 

Read the full news release here. 

More articles on pharmacy:
Walgreens pays $7.5M to resolve claims an employee impersonated a pharmacist
SwedishAmerican opens ScriptCenter, a self-serve pharmacy kiosk
Walgreens CEO talks strategy, skips buyout speculation at annual meeting

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.